Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Crit Care Med. 2022 Feb 7;50(6):924–934. doi: 10.1097/CCM.0000000000005470

Table 1. Baseline characteristics.

y, years; SD, standard deviation; BMI, body mass index; ICU, intensive care unit; C, Celsius.

Variable Control (n=28) Warming (n=28)
Male, n (%) 16 (57) 11 (39)
Age, y (SD) 58.7 (16.8) 58.7 (13.3)
BMI, mean (SD) 33.6 (11.0) 29.5 (9.1)
Body surface area (m2), mean (SD) 2.07 (0.36) 1.97 (0.30)
ICU, n (%)
 Medical 21 (75) 18 (64)
 Surgical 7 (25) 10 (36)
Surgery within 1 week, n (%) 6 (21) 4 (14)
Source, n (%)
 Pneumonia 15 (54) 19 (68)
 Abdominal 4 (14) 3 (11)
 Soft Tissue/Bone 3 (11) 1 (4)
 Urinary 2 (7) 1 (4)
 Other or unknown 4 (14) 4 (14)
Positive Culture, n (%) 13 (46) 20 (71)
 Culture results susceptible to initial antibiotics 11 (85) 20 (100)
Organism, n (%)
 Gram negative 7 (54) 10 (50)
 Gram positive 2 (15) 5 (25)
 Mixed 1 (8) 1 (5)
 Viral 3 (23) 4 (20)
Lactate, mean (SD) 4.8 (3.1) 3.5 (2.7)
Leukocyte count, mean (SD) 17.3 (18.1) 13.6 (7.7)
APACHE-II, mean (SD) 22.1 (5.2) 20.1 (6.5)
SOFA, mean (SD) 8.8 (3.9) 8.0 (3.9)
 Oxygenation score, mean (SD) 2.4 (1.2) 2.5 (1.2)
Calculated temperature 1.5 degrees C above baseline, mean (SD) 37.9 (0.6) 38.0 (0.5)
Time from antibiotics to randomization, mean (SD) 29.7 (16.2) 28.6 (15.6)
Comorbidities, n (%)
 Coronary artery disease 7 (25) 6 (21)
 Congestive heart failure 5 (18) 4 (14)
 Stroke 2 (7) 2 (7)
 Chronic obstructive pulmonary disease 8 (29) 8 (29)
 Diabetes mellitus 10 (36) 8 (29)
 Solid tumor 4 (14) 3 (11)
 Liver disease 9 (32) 5 (18)
 End-stage renal disease 2 (7) 2 (7)